GRAIL, Inc.
132.55USD
+5.4900 (+4.32%)
Computing valuation metrics…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on GRAL.
Valuation
P/E (TTM)
—
P/E (Forward)
—
EV/EBITDA
—
EV/Revenue
31.16x
P/S (TTM)
35.82x
P/B
2.33x
FCF Yield
-5.00%
Dividend Yield
0.00%
Gross Margin
49.71%
Operating Margin
-338.40%
Net Margin
-236.95%
Peer Comparison — Diagnostics & Research
| Company | Mkt Cap | P/E | EV/EBITDA | FCF Yield | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|
| GRALGRAIL, Inc. | $5.92B | — | — | -5.00% | 25.72% | 0.00% |
| TMOThermo Fisher Scientific Inc. | $249.14B | 35.54x | 23.35x | 2.59% | 9.10% | 0.28% |
Subject metrics from SEC filings where available; peer metrics from cached market data.
| $162.04B |
| 38.16x |
| 22.32x |
| 2.93% |
| 8.30% |
| 0.69% |
| AAgilent Technologies, Inc. | $48.79B | 34.14x | 24.61x | 2.17% | 8.10% | 0.59% |
| IQVIQVIA Holdings Inc. | $45.98B | 34.70x | 19.78x | 4.68% | 8.70% | 0.00% |
| WATWaters Corporation | $44.54B | 114.85x | 34.10x | -0.32% | 113.40% | 0.00% |
| IDXXIDEXX Laboratories, Inc. | $44.20B | 39.38x | 27.78x | 2.06% | 9.70% | 0.00% |
| ILMNIllumina, Inc. | $40.68B | 50.26x | 36.40x | 1.96% | 9.40% | 0.00% |
| MTDMettler-Toledo International Inc. | $33.47B | 37.49x | 27.87x | 2.07% | 4.50% | 0.00% |